This is a project that supports the cost for testing and certification of MCST1 and MCST2, which are core parts of the Anyfusion ACPi kit set we are developing. Since history, when medical staff extracts a drug from a drug container with a syringe, positive and negative pressures are generated, making it difficult to introduce and extract the quantity and total amount of the drug. It was hard work.

In addition, it is difficult to extract the entire amount of drug as much as the height at which the needle of the syringe is pierced into the drug container, so medical expenses are wasted due to the increase in waste drugs. In order to minimize the risk of being constantly exposed to the risk of infection due to exposure contamination, developed countries invest a huge amount of money to build a quality hospital environment and manage it. CAM and MCST1 and 2, developed by us that will change the medical history, are the role of the medical staff to stab and withdraw the needle, the negative and positive pressure offset function, and the medical and clinical revolution Oh, infection prevention, as well as replacing the risk and hard work of medical staff The importance of MCST 1 and 2, which are core parts of innovative technology, was selected as a business operator and supported.

Seoul National University Bundang, which introduced a dispensing robot two years ago as a representative domestic major hospital, Shinchon Severance Hospital, which was recently introduced and set up, and Atomic Energy Hospital, where robots are not installed Manual Anyfusion ACPi V100 and Anyfusion containing MCST1 and 2 ACPi Kit set, developed CAM, introduced and demonstrated ACPi technology, which had only conveyed the real and practical functions and performance by word of mouth, to the pharmaceutical department and dispensing team, and came to recognize a completely different technology from robots.

Dispensing using syringes and needles by humans (medical staff) was in a non-closed state, so a clean room and BSC facility were needed and The robot was expensive due to the establishment of its own BSC facility, and a separate sterile facility was required, so a lot of expenses and expenses were invested. But, Anyfusion ACPi system and kit set are all-in-one closed systems from dispensing, mixing, to injection. In addition to anticancer drug preparation, powder preparation preparation, TPN preparation (existingly using a separate device worth 100 million won), PCA balloon, syringe filling, dispensing from large-capacity anticancer drug container, etc. With the capacity and low cost to replace the hospital, both major hospitals decided to conduct a demo to recognize the need for ACPi.

Once the reliability of Anyfusion ACPi performance and function is confirmed, it is physically difficult for hospitals that have not introduced robots as well as hospitals that have introduced robots to not use robots. It is expected that this will be force majeure. In addition, the introduction and use of major hospitals is judged to be a major criterion for the introduction of other hospitals and entry into overseas markets.

It is also expected to have a significant impact on the advancement of HIS-linked APiS in the field of mixing and injecting drugs in wards, intensive care units, operating rooms, and anesthesia departments.

We would like to thank the hospital staff for allowing us to demonstrate, and thank you for your sincere advice and pointing out complementary parts for the development and successful marketization of domestic medical devices.

Thank you.